This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

EDAP Expands Ablatherm-HIFU Into China By Entering Exclusive Distribution Agreement

LYON, France, Aug. 26, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it will expand into the rapidly growing Chinese healthcare market with its Albatherm HIFU device for the treatment of prostate cancer. Ablatherm HIFU will be distributed throughout China by Shaw Han Biomedical Co. Ltd.  This exclusive distribution agreement underscores EDAP's global expansion strategy for HIFU in what is the fastest growing medical device market.  With the largest population in the world, China represents a significant market for prostate cancer treatment as cancer detection rates rise, awareness of treatment options increases and the expanding aging population garners greater access to healthcare. It is an opportune time to commence the regulatory and marketing process in China for EDAP's robotized, quality-of-life preserving device. 

Marc Oczachowski, Chief Executive Officer of EDAP TMS, commented, "This partnership affords a significant market opportunity for EDAP to tap into the rapidly growing medical device market in China. We undertook extensive due diligence to identify the optimal distribution partner to address the large, dynamic and complex Chinese market. This exclusive agreement will involve a two-stage process.  Initially, Shaw Han will be responsible for processing the marketing clearance application with China's State Food and Drug Administration (SFDA) for Ablatherm-HIFU for localized prostate cancer treatment.  Following receipt of SFDA clearance, Shaw Han will lead the promotion, marketing, and distribution of the device in China for four years post approval. As part of the agreement, Shaw Han has committed to purchase a minimum number of Ablatherm HIFU units during the period covered by the two-stage process."

EDAP's distribution partnership with Shaw Han will officially be announced at the Asian Congress of Urology (ACU) to be held in Taiwan on August 27-28, 2010. Together with its partner, EDAP will showcase its state-of-the-art HIFU and lithotripsy technologies at the ACU.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,397.11 +205.74 1.20%
S&P 500 2,013.60 +11.44 0.57%
NASDAQ 4,663.7490 +25.7550 0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs